Sandoz Launches Biosimilar Pyzchiva® (Ustekinumab-Ttwe) In The US, Offering New Treatment ...
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules <li /> Key biosimilar value driver contributes to Sandoz global ...